Evidence map›Paper›PMID 39475641›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2024

Pan-ErbB inhibition impairs cognition via disrupting myelination and aerobic glycolysis in oligodendrocytes.

Xu Hu, Qingyu Zhu, Tianjie Lou, Qianqian Hu, Huashun Li, Yijia Xu, Xiaojie Niu, Li He, Hao Huang, Mengsheng Qiu and 3 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  7. Article
  8. Review
  9. Review
  10. Revisiting the role of ErbBs in oligodendrocyte development.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Xu HuCollege of Life Sciences, Zhejiang University, Hangzhou 310058, China.
Qingyu ZhuDepartment of Physiology, School of Medicine, Southeast University, Nanjing 210009, China.
Tianjie LouInstitute of Life Sciences, College of Life and Environmental Sciences, Hangzhou Normal University, Hangzhou 311121, China.
Qianqian HuInstitute of Life Sciences, College of Life and Environmental Sciences, Hangzhou Normal University, Hangzhou 311121, China.
Huashun LiDepartment of Physiology, School of Medicine, Southeast University, Nanjing 210009, China.
Yijia XuInstitute of Life Sciences, College of Life and Environmental Sciences, Hangzhou Normal University, Hangzhou 311121, China.
Xiaojie NiuInstitute of Life Sciences, College of Life and Environmental Sciences, Hangzhou Normal University, Hangzhou 311121, China.
Li HeInstitute of Life Sciences, College of Life and Environmental Sciences, Hangzhou Normal University, Hangzhou 311121, China.
Hao HuangInstitute of Life Sciences, College of Life and Environmental Sciences, Hangzhou Normal University, Hangzhou 311121, China.
Mengsheng QiuInstitute of Life Sciences, College of Life and Environmental Sciences, Hangzhou Normal University, Hangzhou 311121, China.
Ying ShenDepartment of Neurobiology, Key Laboratory of Medical Neurobiology of Zhejiang Province, Zhejiang University School of Medicine, Hangzhou 310058, China.ORCID 0000-0001-7034-5328
Jie-Min JiaCollege of Life Sciences, Zhejiang University, Hangzhou 310058, China.ORCID 0000-0001-8446-3819
Yanmei TaoDepartment of Physiology, School of Medicine, Southeast University, Nanjing 210009, China.ORCID 0000-0002-4456-5447

Funding

The key project of Zhejiang provincial natural science foundation of China 2022XHSHH004The national natural science foundation of china 2021ZD0201700 31371075 31871030 and 32170956The young scientists project of Zhejiang provincial natural science foundation of China LQ19H090009
6 · The paper itself

Abstract

White matter (WM) abnormalities are an emerging feature of schizophrenia, yet the underlying pathophysiological mechanisms are largely unknown. Disruption of ErbB signaling, which is essential for peripheral myelination, has been genetically associated with schizophrenia and WM lesions in schizophrenic patients. However, the roles of ErbB signaling in oligodendrocytes remain elusive. Here, we used an in vivo pan-ErbB inhibition strategy and demonstrated the functions of endogenous ErbB receptors in oligodendrocytes. Through analyses of the cellular, histological, biochemical, behavioral, and electrophysiological differences in mice with manipulated ErbB activities in oligodendrocytes at different differentiation stages, we found that ErbB signaling regulates myelination and aerobic glycolysis in oligodendrocytes, and both functions are required for working memory. ErbB inhibition in oligodendrocytes at early differentiation stages induces hypomyelination by suppressing the myelinating capacity of newly formed oligodendrocytes. In contrast, ErbB inhibition in mature oligodendrocytes alters neither myelination nor oligodendrocyte numbers, but accelerates axonal conduction decline under energy stress. Mechanistically, ErbB inhibition attenuates K-Ras activities, leading to the reduced expression of lactate dehydrogenase A that promotes aerobic glycolysis in mature oligodendrocytes. Supplementation of L-lactate restores axonal conduction and working memory capacity that are suppressed by ErbB inhibition in mature oligodendrocytes. These findings emphasize the indispensable roles of ErbB signaling in WM integrity and function and provide insights into the multifaceted contributions of WM abnormalities to cognitive impairment.

Indexed as

ErbB ReceptorsGlycolysisMyelin SheathOligodendrogliaAnimalsCell DifferentiationCognitionMemory, Short-TermMiceSchizophreniaSignal TransductionWhite MatterErbB ReceptorsErbB signalinglactatemyelinoligodendrocyte differentiation stageworking memory

Identifiers

PMID39475641
PMCPMC11551437

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.